Flow cytometry is a single-cell analytical technique that uses fluorophore-labeled cell structures or biomarkers to differentiate between cell populations. Through this method, researchers detect the ...

This eBook highlights the latest advancements in flow cytometry and imaging technologies, featuring a curated collection of posters presented at the ELRIG Drug Discovery conference. This resource is ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the global commercial launch of BD Research Cloud 7.0, marking another step forward in its AI-driven life sciences strategy ...

With flow cytometry, as with many technologies that enjoy continuous use, we can see an evolution of capabilities. Spectral analysis, image capture, and artificial intelligence are just a few of the ...

Recent advances in imaging techniques have revolutionised flow cytometry and microscopy by integrating high-throughput cell analysis with high‐resolution imaging. These technologies now harness novel ...

Subjectivity in flow-cytometry data analysis has long been a challenge. Recent advancements in high-speed camera capabilities have led to the integration of morphological features with traditional ...

The Cytometry and Microscopy Shared Resource (CMSR) supports researchers at the Case Comprehensive Cancer Center (Case CCC) by providing access to advanced cytometry and microscopy technologies. This ...

Brian Hall, Product Manager, Imaging Flow Cytometry,1 Stephanie Brunelle, PhD, Product Manager, CellStream,1 Katie Gillis, Product Manager, Microcapillary Flow ...

When generating induced pluripotent stem cells (iPSCs) for use in downstream applications, it is commonplace to perform initial checks for key attributes such as viability and pluripotency. This ...

Please provide your email address to receive an email when new articles are posted on . Imaging mass cytometry appeared feasible and allowed for a more comprehensive overview of triple-negative breast ...

SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned ...

Advancements in immuno-oncology have been moving at an ever-quickening pace. From the development of new CAR-T therapies to a better understanding of the mechanism of action of monoclonal antibody ...